VectraCor, Inc. is a cardio-pulmonary medical device company with products that are PC-Based in order to improve patient outcomes with innovative ECG and Spirometry products. In December of 2014, VectraCor acquired the assets of QRS Diagnostics which enabled VectraCor to provide products to cover the 1st and 3rd disease states globally, Cardiovascular and Lung Disease respectively. VectraCors products are FDA cleared, CE marked and ISO 13485. Our newest ECG technology, VectraplexECG System, is patented worldwide and has over 40 published papers or abstracts from prestigious institutions that have presented at the European Society Cardiology (ESC), American College of Cardiology (ACC), Society of Critical Care Medicine (SCCM) and American College of Emergency Physicians. In June 2018, VectraCor, Inc. announced its VectraplexECG System with CEB® (Cardiac Electrical Biomarker) has received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation of VectraCors VectraplexECG System with CEB® technology by industry experts who serve on Vizients Innovation Council. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organizations care delivery and business model.
VectraCor's Orbit Spirometry is partnered with the American Lung Association (ALA) in educational workshops throughout the United States, teaching health care providers on the advantages of using spirometry for early detection of lung disease.
VectraCor, is expanding globally and looking for international distributor partners to exclusively distribute its products. We also provide OEM manufacturing for ECG and Spirometry Modules.
For additional information visit our website www.vectracor.com. Our products are manufactured in the United States.